www.benefitsandpensionsmonitor.com/news/industry-news/glp-1-drugs-take-a-bite-out-of-fast-food-returns/392827
In this study, with a median follow-up of 25 months, the primary composite end point including cardiovascular death, MI, stroke, and hospitalization for unstable angina occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (HR, 1.02
Within the N-terminal nine amino acids, oxyntomodulin differs from GLP-1 by 2 residues, with Ala8 and Glu9 of GLP-1 replaced by Ser2 and Gln3 in oxyntomodulin (Fig
Objective : To estimate the prevalence of diabetic retinopathy among individuals taking insulin who attend primary healthcare in the municipality of Jardinpolis, So Paulo state, Brazil
Note that higher doses of IGF-1 especially IGF-1 LR3 can cause hypoglycemia due to its effect on glucose transport